# US 2009/0253146 A1 · Methods of expressing integrin beta6 subunits

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2009/0253146 A1
- Document ID: US20090253146A1
- Status: Published application
- Kind: A1
- Application number: 11/825,510
- Filed: 2007-07-06
- Published: 2009-10-08
- Earliest claimed: 1991-07-11
- Assignees: The Regents of the University of California
- Inventors: Dean Sheppard; Robert Pytela
- Web page: https://patentgrep.com/patent/US20090253146A1

## CPC

- C07K 14/70546: {Integrin superfamily}
- C07K 16/30: from tumour cells
- C07K: PEPTIDES (peptides in foodstuffs A23; obtaining protein compositions for foodstuffs, working-up proteins for foodstuffs A23J; preparations for medicinal purposes A61K; peptides containing beta-lactam rings C07D; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, C07D; ergot alkaloids of the cyclic peptide type C07D519/02; macromolecular compounds having statistically distributed amino acid units in their molecules, i.e. when the preparation does not provide for a specific; but for a random sequence of the amino acid units, homopolyamides and block copolyamides derived from amino acids C08G69/00; macromolecular products derived from proteins C08H1/00; preparation of glue or gelatine C09H; single cell proteins, enzymes C12N; genetic engineering processes for obtaining peptides C12N15/00; compositions for measuring or testing processes involving enzymes C12Q; investigation or analysis of biological material G01N33/00)

## Abstract

The present invention provides substantially pure integrins containing a novel β subunit designated as β6. The novel β6 subunit forms heterodimers with αV and αF. Methods of controlling cell adhesion using the β6-containing integrins are also provided.

## Claims

### Claim at position 1

1-13. (canceled)

### Claim 14

A method of preventing the binding of a cell expressing a β6-containing integrin to ligand capable of binding to a said β6-containing integrin, comprising blocking the binding of the β6-containing integrin and the ligand.

### Claim 15 (depends on 14)

The method of claim 14, wherein the blocking is effected by binding the β6-containing integrin with a reagent specific thereto.

### Claim 16 (depends on 14)

The method of claim 14, wherein the blocking is effected by binding the ligand of the β6-containing integrin with a reagent specific for the ligand.

### Claim 17 (depends on 15)

The method of claim 15, wherein the reagent is an RGD-containing peptide or polypeptide.

### Claim 18 (depends on 15)

The method of claim 15, wherein the reagent is a ligand fragment containing an integrin binding site.

### Claim 19

A method of detecting a ligand that binds a β6-containing integrin, comprising contacting the β6-containing integrin with a solution containing the ligand suspected of binding β6-containing integrins and detecting the presence of the ligand bound to the β6-containing integrin.

### Claim 20

A method of increasing cell adhesion in cells expressing a β6-containing integrin, comprising overexpressing the β6-containing integrin in a cell.

### Claim 21

A method of decreasing cell adhesion in cells expressing a β6-containing integrin comprising binding the β6-containing integrin with a ligand.
